Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01890954 · ClinicalTrials.gov registry record · NA

Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT01890954 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01890954, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The purpose of this study is to use a closed-loop Control-to-Range (CTR) system in adolescents with type 1 diabetes in an outpatient setting, and to evaluate the CTR system's ability to significantly improve blood glucose levels when an insulin bolus is omitted for a 30 gram carbohydrate snack and when insulin bolus is insufficient for the amount of carbohydrates consumed for a meal. The primary objective of this study is to use a closed-loop Control-to-Range (CTR) system to significantly reduce the post-prandial blood glucose excursion in adolescents with type 1 diabetes who omit and/or under-bolus insulin for either snacks or meals. Up to 20 subjects aged ≥13 and ≤18 years old will be tested.

Interventions

  • DEVICE Diabetes Assistant (DiAs)

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2013-08
Est. Completion 2014-02
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT01890954

The ClinicalTrials.gov registry entry for NCT01890954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diabetes Assistant (DiAs) is the first listed.

NCT01890954 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01890954 about?

NCT01890954 is a clinical study titled "Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents". The purpose of this study is to use a closed-loop Control-to-Range (CTR) system in adolescents with type 1 diabetes in an outpatient setting, and to evaluate the CTR system's ability to significantly improve blood glucose levels when an insulin bolus is omitted for a 30 gram carbohydrate snack and w...

What is the current status of trial NCT01890954?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2013-08. Estimated completion is 2014-02.

What interventions are being tested in trial NCT01890954?

The interventions under investigation include: Diabetes Assistant (DiAs) (DEVICE).

Who is sponsoring clinical trial NCT01890954?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.